Following the issuance of health alerts by the Federal Commission for Protection against Sanitary Risks (Cofepris) regarding counterfeit Ozempic pens, a medication for adults with diabetes, the Sonora State Health Department is urging the public to verify the product before purchasing it.
Following the health alerts issued by Cofepris on March 26 and May 25, 2026, the Sonora State Government, through the Public Health Department (SSP) and the Sonora State Commission for Protection against Sanitary Risks (Coesprisson), is asking users of the medication to exercise extreme caution due to the identification of these counterfeit products, which require medical supervision for safe use.
The SSP reiterated the importance of purchasing medications only from formal establishments, such as authorized pharmacies, and avoiding their purchase through social media, websites, mobile applications, markets, street markets, or any informal sales point.
Also read: Three puma cubs born at the Sonora Ecological Center; it is one of the emblematic species of the ecosystems of northern Mexico
According to the health alert issued on March 26, Cofepris (Federal Commission for Protection against Sanitary Risks) identified counterfeit Ozempic 1 mg, semaglutide, injectable solution in a pre-filled pen, with lot number JS7A925 on the secondary packaging and an expiration date of 06/2026, as well as lot number MP5E511 on the pre-filled pen and an expiration date of 07/2025.
Likewise, in an alert issued on May 25, 2026, the health authority reported counterfeit OZEMPIC 0.25 mg-0.5 mg/dose, semaglutide, injectable solution in a pre-filled pen, with lot number PP5K617 and an expiration date of 08/2026.
The Ministry of Health recommends carefully checking packaging, lot numbers, expiration dates, and product condition before using any medication.
If any anomalies, differences in packaging, text in another language, signs of tampering, or lot numbers flagged by health authorities are detected, use should be avoided immediately.
Likewise, individuals who have used any of these products with irregular characteristics are asked to discontinue use and consult a healthcare professional for a medical evaluation. Any adverse reactions should also be reported to [email protected], [email protected], or through the VigiRam platform.
The state agency reiterated that self-medication can endanger health, therefore all treatments must be prescribed and supervised by medical personnel.
Source: eluniversal
